Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Other Current Receivables: ₺1,749 Mil (As of Mar. 2026)


IST:GENIL Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
87 GF Score
Price ₺8.97
GF Value ₺8.16
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Other Current Receivables?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS IST:GENIL -0.88% 87 Other Current Receivables is ₺1,749 Mil as of Mar. 2026. GuruFocus rates IST:GENIL with a GF Score™ of 87/100 and a GF Value™ of ₺8.16 (Fairly Valued). The stock has 5 warning signs investors should review.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Other Current Receivables for the quarter that ended in Mar. 2026 was ₺1,749 Mil.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's quarterly Other Current Receivables declined from Sep. 2025 (₺1,702.03 Mil) to Dec. 2025 (₺964.24 Mil) but then increased from Dec. 2025 (₺964.24 Mil) to Mar. 2026 (₺1,748.83 Mil).

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's annual Other Current Receivables declined from Dec. 2023 (₺1,110.05 Mil) to Dec. 2024 (₺763.36 Mil) but then increased from Dec. 2024 (₺763.36 Mil) to Dec. 2025 (₺964.24 Mil).

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Other Current Receivables Related Terms

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Other Current Receivables Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 39.87 842.41 1,110.05 763.36 964.24

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,347.35 1,567.77 1,702.03 964.24 1,748.83
IST:GENIL
87GF Score
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₺1,749 Mil mean?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) has a Other Current Receivables of ₺1,749 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Other Current Receivables too high?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Other Current Receivables is ₺1,749 Mil. Overall, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Other Current Receivables compare to ZTS and UTHR?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Other Current Receivables of ₺1,749 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Other Current Receivables is ₺1,749 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) is currently considered Fairly Valued. The stock's GF Value™ is ₺8.16, compared to a current price of ₺8.97 — trading 9.9% above its estimated fair value. The current Other Current Receivables is ₺1,749 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL), the current Other Current Receivables is ₺1,749 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Overvalued in 2026?

Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock appears to be overvalued. The current stock price of ₺8.97 is trading 9.9% above its estimated GF Value™ of ₺8.16. GuruFocus considers Gen Ilac Veglik Urunlerinayi ve Ticaret AS to be Fairly Valued.

Key valuation signals for IST:GENIL:

  • Other Current Receivables: ₺1,749 Mil
  • GF Value™: ₺8.16 vs. price of ₺8.97 (9.9% above fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the IST:GENIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Business Description

Address Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.
87GF Score

Get the complete analysis for IST:GENIL

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺8.97
Price
₺8.16
GF Value